Bi-Specific shRNA that Simultaneously Downregulates mTOR & STAT3
Time: 3:00 pm
day: Day Two
Details:
- Introducing a new approach for RNAi therapy using Bi-specific shRNA
- Using our bioinformatic platform to determine prominent genes in specific diseases such as mTOR and STAT3 genes in cancer
- Determine the therapeutic effect of naked Bi-specific shRNA vs using a viral carrier for Bi-specific shRNA
